Evaluation of a Novel Artificial Pancreas: Closed Loop Glycemic Control System With Continuous Blood Glucose Monitoring

Artificial Organs

Volumn 37, Issue 4, 2013, Pages

  Tsukamoto, Yuuki ^a   Kinoshita, Yoshihiko ^c   Kitagawa, Hiroyuki ^a   Munekage, Masaya ^a   Munekage, Eri ^a   Takezaki, Yuka ^a   Yatabe, Tomoaki ^b   Yamashita, Koichi ^b   Yamazaki, Rie ^b   Okabayashi, Takehiro ^a   Tarumi, Masatoshi ^c   Kobayashi, Masaki ^c   Mishina, Suguru ^c   Hanazaki, Kazuhiro ^a  

^a KOCHI UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c Nikkiso Co Ltd   (Japan)

Author keywords

Artificial endocrine pancreas; Blood glucose monitoring; Closed loop glycemic control system; Glucose clamp study

Indexed keywords

ANIMALS; ARTIFICIAL ORGANS; BLOOD; CLOSED LOOP CONTROL SYSTEMS; ERRORS; INTENSIVE CARE UNITS;

ARTIFICIAL ENDOCRINE PANCREAS; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; CLINICAL FEASIBILITY; CLOSED-LOOP; CLOSED-LOOP GLYCEMIC CONTROL SYSTEM; ERROR GRID ANALYSIS; GLUCOSE CLAMP STUDY; GLYCEMIC CONTROL; USER FRIENDLY;

GLUCOSE;

GLUCOSE;

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE MONITORING; DIABETIC PATIENT; DOG; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLYCEMIC CONTROL; HYPOGLYCEMIA; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 84875937108     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/aor.12068     Document Type: Article

References (46)

1. van den Berghe G, Wouters P, Weekers F, etal. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
2. van den Berghe G, Wilmer A, Hermans G, etal. Intensive insulin therapy in the medical ICU. N Engl J Med 2006;354:449-461.
3. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, etal. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1297.
4. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 2006;105:244-252.
5. Kawamori R, Shichiri M, Goriya Y, Yamasaki Y, Shigeta Y, Abe H. Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance, assessed by the artificial beta cell. Acta Endocrinol 1978;87:339-351.
6. Hoshino M, Haraguchi Y, Mizushima I, Sakai M. Recent progress in mechanical artificial pancreas. J Artif Organs 2009;12:141-149.
7. Clinical Study Implementation Committee of The Japanese Journal of Artificial Organs. Artificial endocrine pancreas (in Japanese). Jinko Zoki (The Japanese Journal of Artificial Organs) 2006;35(Suppl.):66-68.
8. Hanazaki K, Nosé Y, Brunicardi FC. Artificial endocrine pancreas: a review. J Am Coll Surg 2001;193:310-322.
9. Kono T, Hanazaki K, Yazawa K, etal. Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs. Artif Organs 2005;29:83-87.
10. Okabayashi T, Nishimori I, Maeda H, Yamashita K, Yatabe T, Hanazaki K. Effect of intensive insulin therapy using a closed loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009;32:1425-1427.
11. Okabayashi T, Nishimori I, Maeda H, etal. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial. Arch Surg 2009;144:933-937.
12. Okabayashi T, Nishimori I, Yamashita K, etal. Risk factors and predictors for surgical site infection after hepatic resection. J Hosp Infect 2009;73:47-53.
13. Okabayashi T, Hanazaki K, Maeda H, etal. Intensive insulin therapy by using a closed loop glycemic control system on hepato-biliary-pancreatic surgery (in Japanese). Tan to Sui 2009;30:281-287.
14. Yatabe T, Yamazaki R, Kitagawa H, etal. The evaluation of the ability of closed-loop glycemic control device to maintain the blood glucose concentration in intensive care unit patients. Crit Care Med 2011;39:575-578.
15. Nishida K, Shimoda S, Ichinose K, Araki E, Shichiri M. What is artificial endocrine pancreas? Mechanism and history. World J Gastroenterol 2009;15:4105-4110.
16. Maeda H, Okabayashi T, Yatabe T, Yamashita K, Hanazaki K. Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy. World J Gastroenterol 2009;15:4111-4115.
17. Okabayashi T, Maeda H, Sun ZL, Montgomery RA, Nishimori I, Hanazaki K. Perioperative insulin therapy using a closed-loop artificial endocrine pancreas after hepatic resection. World J Gastroenterol 2009;15:4116-4121.
18. Hanazaki K, Maeda H, Okabayashi T. Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol 2009;15:4122-4125.
19. Yamashita K, Yatabe T. Intraoperative glycemic control procedures and the use of an artificial pancreas. World J Gastroenterol 2009;15:4126-4131.
20. Hirasawa H, Oda S, Nakamura M. Blood glucose control in patients with severe sepsis and septic shock. World J Gastroenterol 2009;15:4132-4136.
21. Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol 2009;15:4137-4142.
22. Takahashi G, Sato N, Matsumoto N, etal. Preliminary study on glucose control with an artificial pancreas in postoperative sepsis patients. Eur Surg Res 2011;47:32-38.
23. Kawahito S, Kitahata H, Kitagawa T, Oshita S. Intensive insulin therapy during cardiovascular surgery. J Med Invest 2010;57:191-204.
24. Hasegawa A, Iwasaka H, Hagiwara S, etal. Anti-inflammatory effects of perioperative intensive insulin therapy during cardiac surgery with cardiopulmonary bypass. Surg Today 2011;41:1385-1390.
25. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010;40:1-7.
26. Yamashita K, Okabayashi T, Yokoyama T, etal. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008;106:160-163.
27. Yamashita K, Okabayashi T, Yokoyama T, etal. Accuracy and reliability of continuous blood glucose monitoring in post-surgical patients. Acta Anaesthesiol Scand 2009;53:66-71.
28. Maeda H, Okabayashi T, Nishimori I, Yamashita K, Sugimoto T, Hanazaki K. Hyperglycemia during hepatic resection: continuous monitoring of blood glucose concentration. Am J Surg 2010;199:8-13.
29. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Gastrointest Liver Physiol 1979;237:214-223.
30. Emoto M, Nishizawa Y, Maekawa K, etal. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999;22:818-822.
31. Komatsu M, Emoto M, Tamura Y, etal. Standardization for glucose clamp using a bed-side type artificial endocrine pancreas (in Japanese). J Pract Diabetes 2009;26:557-562.
32. Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.
33. Maran A, Crepaldi C, Tiengo A, etal. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter analysis. Diabetes Care 2002;25:347-352.
34. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004;27:1922-1928.
35. Clarke WL, Anderson S, Farhy L, etal. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005;28:2412-2417.
36. Wentholt IM, Hoekstra JB, Devries JH. A critical appraisal of the continuous glucose-error grid analysis. Diabetes Care 2006;29:1805-1811.
37. Rhee SY, Chon S, Koh G, etal. Clinical experience of an iontophoresis based glucose measuring system. J Korean Med Sci 2007;22:70-73.
38. Kovatchev B, Anderson S, Heinemann L, Clarke W. Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care 2008;31:1160-1164.
39. Kost GJ, Vu HT, Lee JH, etal. Multicenter study of oxygen-sensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med 1998;26:581-590.
40. Mori A, Lee P, Yokoyama T, etal. Evaluation of artificial pancreas technology for continuous blood glucose monitoring in dogs. J Artif Organs 2011;14:133-139.
41. Emoto M, Nishizawa Y. Clinical index of insulin resistance assessed by glucose clamp technique (in Japanese). Jpn J Diabetes Master Clin 2009;7:219-224.
42. Tsukamoto Y, Okabayashi T, Hanazaki K. Progressive artificial endocrine pancreas: the era of novel perioperative blood glucose control for surgery. Surg Today 2011;41:1344-1351.
43. Hanazaki K, Munekage M, Okabayashi T. What is the optimal blood glucose range to improve morbidity and mortality in surgical patients? Ann Surg 2011;254:671-672.
44. Hanazaki K, Okabayashi T. What should the targeted range of blood glucose levels be to reduce the incidence of surgical site infection following general surgery? Arch Surg 2011;146:368-369.
45. Hanazaki K, Munekage M, Okabayashi T. What is the best way to guarantee postoperative glycemic control? J Am Coll Surg 2011;212:915-916.
46. Hanazaki K, Kitagawa H, Okabayashi T. Determination of the optimal perioperative blood glucose level to reduce surgical site infection in diabetic patients. J Am Coll Surg 2011;213:198-199.